Immucell Corp.

+0.15 (+1.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)73.41M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4 Million
Adjusted EPS-$0.04
See more estimates
10-Day MA$9.27
50-Day MA$9.24
200-Day MA$9.58
See more pivots

Immucell Corp. Stock, NASDAQ:ICCC

56 Evergreen Drive, Portland, Maine 04103
United States of America
Phone: +1.207.878.2770
Number of Employees: 61


ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.